Synthetic Biology Market Trends, Share, Growth and Future Analysis

The global synthetic biology market is growing, due to increasing support from government organizations, and growing geriatric population. In addition, the innovative and advanced applications of synthetic biology, increasing research activities, and increasing R&D investments in drug discovery and development are also supporting the growth of this market.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/synthetic-biology-market/report-sample

On the basis of type of segment, the technology segment is expected to be the largest market and would witness fastest growth during the forecast period. Among the application segment, pharmaceutical and diagnostic had the largest market size in the global market in 2014.

The increasing support from government organizations and growing geriatric population are playing a pivotal role in the growth of this market. Some of the major organizations include National Science Foundation (NSF), National Aeronautics and Space Administration (NASA), Centre for Chemical and Synthetic Biology (CCSB), Synthetic Biology Engineering Research Center (SynBERC), and International Association Synthetic Biology (IASB). These organizations are providing support in form of funding, and initiatives implemented by them for basic and applied research with their respective goals.

Browse report at: https://www.psmarketresearch.com/market-analysis/synthetic-biology-market

The key companies operating in the global synthetic biology market include E. I. du PONT de Nemours and Company, Amyris Inc., GenScript USA Inc., Intrexon Corporation, Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Royal DSM, Novozymes A/S, New England Biolabs Inc., and Integrated DNA Technologies Inc.

Air Quality Monitoring Market Size, Growth Drivers, Development and Forecast by 2023

The AQM market is primarily driven by increasing level of air pollution across the globe, increasing awareness regarding environmental and healthcare implications of air pollution and favorable government regulations for AQM.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/air-quality-monitoring-devices-market/report-sample

Globally, North America was the largest market for AQM in 2015, and it is expected to witness considerable growth during the forecast period. The North American AQM market accounted the largest share in the global market due to increasing number of patients with respiratory disorders, increasing awareness regarding environmental and healthcare implication of air pollution, and increasing pollution level.

Urbanization has significantly changed the lifestyle and the environment. According to WHO, more than 50% of the world’s population live in urban areas. It is expected that by 2050, 70% of the world’s population will live in towns and cities. The air pollution level across the globe, espcially in urban areas is increasing due to the rapidly growing construction, increasing number of vehicles, and increasing industrialization. The increasing level of air pollution has significantly threatened the health of an individual, thus creating huge demand for the AQM market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/air-quality-monitoring-devices-market

Some of the major players operating in the AQM market include Thermo Fisher Scientific Inc., Merck KGaA, Teledyne Technologies Incorporated, HORIBA, Ltd., Emerson Electric Co., General Electric Company, TSI Incorporated, 3M Company, and Siemens AG.

GLOBAL AQM MARKET SEGMENTATION
By Product Type
• Indoor air quality monitors
o Fixed indoor air quality monitors
o Portable indoor air quality monitors
• Outdoor air quality monitors
o Portable outdoor air quality monitors
o Fixed outdoor air quality monitors
o Dust and particulate air quality monitors
o AQM stations
By Pollutant Type
• Chemical Pollutant
• Physical Pollutant
• Biological Pollutant
By Sampling Method
• Continuous monitoring
• Manual monitoring
• Passive monitoring
• Intermittent monitoring
By End User
• Government agencies and academic institutes
• Commercial and residential user
• Petrochemical industry
• Power generation plants
• Pharmaceutical industry
• Others

Source: P&S Intelligence

Growth in Healthcare Industry Drives the Global Cleanroom Doors Market During Forecast Period

The cleanroom doors market is growing due to increasing utilization of cleanroom doors in pharmaceuticals, biotechnology and medical device industry, hospitals, and research laboratories and institutes. The growing demand of cleanrooms globally is resulting in increased demand of cleanroom doors.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/cleanroom-doors-market/report-sample

Cleanroom doors are vital component of cleanrooms. Cleanroom doors with low quality may cause degradation and alteration of the quality of products manufactured in cleanrooms. Doors are required to be airtight with high cycle speed, to keep the clean room free from contaminants. Therefore, the need for improved and effective quality of environmental conditions while preparing pharmaceutical and other healthcare products is expected to fuel the demand for cleanroom doors in the coming years. As a result, the demand for cleanroom doors is expected to increase during the forecast period.

Browse report at: https://www.psmarketresearch.com/market-analysis/cleanroom-doors-market


In addition, the growth of pharmaceuticals and biotechnology industry in various countries across the globe are leading to increased demand of cleanrooms and cleanroom doors. Various pharmaceuticals, such as vaccines, injections and ointments, need to be prepared in microbes and particulates free environment. Cleanroom offers suitable environmental conditions by lowering the level of pollutants, such as dust, chemical vapors, microbes and aerosol particles. Various medical devices, such as implants and surgical equipment need to be manufactured in special environmental conditions with minimal pollutants. Various legislations have been passed worldwide regarding the manufacturing of medical devices in cleanrooms. These legislations focus on the manufacturing of contamination free products which can be used directly for internal purposes without the risk of infection.

Source: P&S Intelligence

North America Wound Closure Products Market Overview, Size, Growth and Forecast to 2022

The wound closure products market size is set to reach $14.6 billion by 2022, growing at a CAGR of 6.3% between 2016-2022. The market is driven by factors such as growing geriatric population, increasing volume of surgeries, and increase in road accidents. In addition, increase in burn cases across the globe and increasing incidence of chronic wounds is also driving the growth of the market.

Get a Sample Copy of This Report at: https://www.psmarketresearch.com/market-analysis/wound-closure-products-market/report-sample

In 2015, North America held the largest share in the global wound closure market whereas, Asia-Pacific market is expected to witness fastest growth, with a CAGR of 7.0% during the period 2016– 2022.

The high cost of wound closure products limits the growth of the wound closure products market. High cost of wound closure products, such as adhesives and tissue sealants, haemostats, sutures and wound closure strips limits the affordability of the users. In addition, the manufacturing of these products also requires material with specific characteristic features, thus leading to higher cost. Moreover, raw materials required for manufacturing of wound closure products have specific requirements.

Companies in the wound closure products market are undergoing mergers and acquisitions to improve their market share. For instance, in August 2016, Derma Sciences Inc. completed the acquisition of privately held BioD LLC with an immediate transaction value of $21.3 million and a potential total transaction value of an estimated $77.8 million. This includes an upfront payment of cash and common stock of $21.3 million, as well as potential product regulatory milestone payments in aggregate estimated to be up to $30.0 million and earn outs based on incremental net sales growth of up to $26.5 million. BioD LLC is a biotechnology company involved in the development and commercialization of novel and biologic products. The acquisition has been made to expand Derma Sciences’ regenerative medicine and advanced wound care products portfolio.

Explore Report at: https://www.psmarketresearch.com/market-analysis/wound-closure-products-market

Some of the key companies operating in the wound closure products market include 3M Company, Medtronic plc, Smith and Nephew plc, CryoLife Inc., DeRoyal Industries Inc., Pfizer Inc., Derma Sciences Inc., Johnson and Johnson, B. Braun Melsungen AG and Baxter International Inc.